BioNexus Gene Lab Corp. 完成对 Fidelion Diagnostics 的战略投资;获得全球AI肿瘤平台15%股权及Vitaguard™在东南亚的独家权利

美股速递
Dec 03, 2025

BioNexus Gene Lab Corp. 完成对 Fidelion Diagnostics 的战略投资;获得全球AI肿瘤平台15%股权及Vitaguard™在东南亚的独家权利

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10